Ranbaxy Laboratories Limited
Products
Full Paper
Price: £95.00
Description: The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Published Date: 08/06/2011
Category: Therapies & Markets
Research Report Decription
Ranbaxy
Laboratories Limited - Strategy and SWOT Report, is a source of comprehensive
company data and information. The report covers the company’s structure,
operation, SWOT analysis, product and service offerings and corporate actions,
providing a 360˚ view of the company.
Features:
- Detailed information on Ranbaxy
Laboratories Limited required for business and competitor intelligence needs
- A study of the major internal and
external factors affecting Ranbaxy Laboratories Limited in the form of a SWOT
analysis
- An in-depth view of the business model
of Ranbaxy Laboratories Limited including a breakdown and examination of key
business segments
- Intelligence on Ranbaxy Laboratories
Limited’s mergers and acquisitions (M&A), strategic partnerships and
alliances, capital raising, private equity transactions, and financial and legal
advisors
- News about Ranbaxy Laboratories Limited,
such as business expansion, restructuring, and contract wins
-
Large number of easy-to-grasp charts and
graphs that present important data and key trends
Key Questions Answered:
- Gain understanding of the Ranbaxy Laboratories
Limited and the factors that influence its strategies
- Track strategic initiatives of the
company and latest corporate news and actions
- Assess Ranbaxy Laboratories Limited as a
prospective partners, vendor or supplier
- Support sales activities by
understanding your customers' businesses better
- Stay up to date on Ranbaxy Laboratories
Limited’s business structure, strategy and prospects
Companies Mentioned:
Ranbaxy Laboratories Ltd
Paper Highlights:
Ranbaxy
Laboratories (Ranbaxy) is an India-based company. The company, with its
subsidiaries, operates as an integrated international pharmaceuticals
organization with businesses encompassing the value chain in the marketing,
production and distribution of pharmaceuticals products. The company operates
in India, Europe, North America and Asia Pacific. It is headquartered in
Gurgaon, India and employs 12,995 people. The company recorded revenues of
INR75,970.4 million (approximately $1,570.3 million) during the financial year
(FY) ended December 2009, an increase of 2.5% over FY2008. The operating profit
of the company was INR11,991 million (approximately $247.9 million) during
FY2009, compared to an operating loss of INR2,626.3 (approximately $54.3
million) in FY2008. The net profit was INR2,964.9 million (approximately $61.3
million) in FY2009, compared to a net loss of INR9,512.1 (approximately $196.6
million) in FY2008. * Calculated using the constant currency conversion rate of
INR1 = $0.02067 for the financial year ended December 2009